These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 16924691

  • 1. Anti-dsDNA antibody testing by Farr and ELISA techniques is not equivalent.
    Neogi T, Gladman DD, Ibanez D, Urowitz M.
    J Rheumatol; 2006 Sep; 33(9):1785-8. PubMed ID: 16924691
    [Abstract] [Full Text] [Related]

  • 2. Clinical significance of ELISA positive and immunofluorescence negative anti-dsDNA antibody.
    Kim KH, Han JY, Kim JM, Lee SW, Chung WT.
    Clin Chim Acta; 2007 May 01; 380(1-2):182-5. PubMed ID: 17355877
    [Abstract] [Full Text] [Related]

  • 3. Diagnosing systemic lupus erythematosus: new-generation immunoassays for measurement of anti-dsDNA antibodies are an effective alternative to the Farr technique and the Crithidia luciliae immunofluorescence test.
    Antico A, Platzgummer S, Bassetti D, Bizzaro N, Tozzoli R, Villalta D, Study Group on Autoimmune Diseases of the Italian Society of Laboratory Medicine (SIMeL).
    Lupus; 2010 Jul 01; 19(8):906-12. PubMed ID: 20179169
    [Abstract] [Full Text] [Related]

  • 4. [Capacity to predict a recurrence of lupus erythematosus using double-stranded anti-DNA antibodies and Farr technique].
    Massardo L, Martínez ME, Pérez R, Ramírez V, Foradori A, González A, Radrigán F, Gutiérrez F, Jacobelli S.
    Rev Med Chil; 1999 Apr 01; 127(4):411-20. PubMed ID: 10451606
    [Abstract] [Full Text] [Related]

  • 5. BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus.
    Bardin N, Desplat-Jego S, Daniel L, Jourde Chiche N, Sanmarco M.
    Autoimmunity; 2009 Jan 01; 42(1):63-8. PubMed ID: 19127456
    [Abstract] [Full Text] [Related]

  • 6. [Comparison of indirect immunofluorescence on Crithidia luciliae of Farr test, and immunoenzymatic methods for the screening of anti-native DNA autoantibodies].
    Chrétien P, Dauvin M, Hélin P, Ocwieja T, Absalon YB, Johanet C.
    Ann Biol Clin (Paris); 1994 Jan 01; 52(9):645-50. PubMed ID: 7872513
    [Abstract] [Full Text] [Related]

  • 7. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
    Salonen EM, Miettinen A, Walle TK, Koskenmies S, Kere J, Julkunen H.
    Ann Rheum Dis; 2004 Oct 01; 63(10):1250-4. PubMed ID: 15361381
    [Abstract] [Full Text] [Related]

  • 8. Comparison of three anti-dsDNA assays: performance and correlation with systemic lupus erythematosus disease activity.
    Venner AA, Ibañez D, Gladman DD, Urowitz MB, MacKinnon A, Blasutig IM, Yip PM.
    Clin Biochem; 2013 Mar 01; 46(4-5):317-20. PubMed ID: 23246539
    [Abstract] [Full Text] [Related]

  • 9. Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus.
    Mok CC, Ho LY, Leung HW, Wong LG.
    Transl Res; 2010 Dec 01; 156(6):320-5. PubMed ID: 21078493
    [Abstract] [Full Text] [Related]

  • 10. Association of alpha-actinin-binding anti-double-stranded DNA antibodies with lupus nephritis.
    Renaudineau Y, Croquefer S, Jousse S, Renaudineau E, Devauchelle V, Guéguen P, Hanrotel C, Gilburd B, Saraux A, Shoenfeld Y, Putterman C, Youinou P.
    Arthritis Rheum; 2006 Aug 01; 54(8):2523-32. PubMed ID: 16868973
    [Abstract] [Full Text] [Related]

  • 11. Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus.
    Mosca M, Chimenti D, Pratesi F, Baldini C, Anzilotti C, Bombardieri S, Migliorini P.
    J Rheumatol; 2006 Apr 01; 33(4):695-7. PubMed ID: 16583471
    [Abstract] [Full Text] [Related]

  • 12. A new oligonucleotide-based ELISA for the detection of anti-double-stranded DNA antibodies.
    Radice A, Sinico RA.
    Autoimmunity; 2006 Mar 01; 39(2):113-9. PubMed ID: 16698667
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of the Farr radioimmunoassay, 3 commercial enzyme immunoassays and Crithidia luciliae immunofluorescence test for diagnosis and activity assessment of systemic lupus erythematosus.
    Launay D, Schmidt J, Lepers S, Mirault T, Lambert M, Kyndt X, Reumaux D, Duhamel A, Hachulla E, Hatron PY, Prin L, Dubucquoi S.
    Clin Chim Acta; 2010 Jul 04; 411(13-14):959-64. PubMed ID: 20303931
    [Abstract] [Full Text] [Related]

  • 17. Anti-serum amyloid component P antibodies in patients with systemic lupus erythematosus correlate with disease activity.
    Zandman-Goddard G, Blank M, Langevitz P, Slutsky L, Pras M, Levy Y, Shovman O, Witte T, Doria A, Rovensky J, Shoenfeld Y.
    Ann Rheum Dis; 2005 Dec 04; 64(12):1698-702. PubMed ID: 16014675
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker.
    Simón JA, Cabiedes J, Ortiz E, Alcocer-Varela J, Sánchez-Guerrero J.
    Rheumatology (Oxford); 2004 Feb 04; 43(2):220-4. PubMed ID: 13130152
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.